Lincomycin Hydrochloride Anhydrous

Specifications

859-18-7CAS Number

212-726-7EC Number

(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochlorideIUPAC Name

C18H35ClN2O6SChemical Formula

443 g/molMolecular Weight

Lincomycin hydrochloride; 859-18-7; LINCOMYCIN HCL; Lincomix 20; Lincomycin hydrochloride anhydrous; Lincomix; DTXSID7047803; GCW8Y9936L; Lincomycin soluble; Lincolnensin hydrochloride; DTXCID9027780; Lincomycin hydrochloride anhdrous; D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2S-trans)-; NSC70731; NSC-70731; NSC-757092; Linco Soluble; LinxMed-SP; Lincomix 50; LincoBac 300; LincoMed 100; Lincosol Soluble Powder; RefChem:582700; LINCOMIX Soluble Powder; LINCOMYCIN 300; LincoMed 100, LincoMed 300; Lincomycin Hydrochloride Soluble Powder; 212-726-7; methyl 6,8-dideoxy-6-(((4R)-1-methyl-4-propyl-L-prolyl)amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside hydrochloride anhydrous; Lincolnensin hydrochloride monohydrate; Lincomycin (as hydrochloride); Lincomycin hydrochloride usp; M6T05Z2B68; Frademicina; Lincocin; MFCD00083647; Mycivin; Lincomycin HCl (Lincocin); Lincomycin (hydrochloride); (2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride; Pura Ject 100; NCGC00159326-02; Lincolnensin, hydrochloride; NSC 70731; C18H35ClN2O6S; Antibiotic 124a, hydrochloride; Lincogap; U 10149a; D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1); Lincocin Hydrochloride; U10149A; (2S,4R)-N-{(1S)-2-hydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-2-pyranyl]propyl}-1-methyl-4-propylpyrrolidine-2-carboxamide Hydrochloride; UNII-GCW8Y9936L; Lincomycin (hydrochloride hydrate); EINECS 212-726-7; CAS-859-18-7; EC 212-726-7; Lincomycin Monohydrochloride; Lincomycin hydrochloride CRS; SCHEMBL192964; MSK7802A; orb1309148; HY-B0417A; MSK7802A-100M; MSK7802A-1000M; Tox21_111575; EBC-11104; MFCD22631533; AKOS024375415; Tox21_111575_1; AL16775; CCG-220302; ANHYDROUS LINCOMYCIN HYDROCHLORIDE; LINCOMYCIN HYDROCHLORIDE [WHO-DD]; NCGC00159326-03; (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride; AS-13720; Lincomycin hydrochloride, >=90% (TLC); SY006929; Lincomycin hydrochloride, >=95.0% (TLC); L0166; NS00076397; ST51016093; LINCOMYCIN HYDROCHLORIDE ANHDROUS [MI]; EN300-6494894; ANHYDROUS LINCOMYCIN HYDROCHLORIDE [MART.]; Lincomycin hydrochloride for system suitability CRS; Q27279041; Lincomycin hydrochloride Solution in Methanol, 100ug/mL; Lincomycin hydrochloride Solution in Methanol, 1000ug/mL; Lincomycin hydrochloride, BioReagent, suitable for cell culture; Lincomycin hydrochloride, British Pharmacopoeia (BP) Reference Standard; (2s,4r)-N-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboximidic acid hydrochloride; (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide;hydrochloride; (2S,4R)-N-[(1R,2R)-2-Hydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-2-pyranyl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide Hydrochloride; (2S-TRANS)-METHYL 6,8-DIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-D-ERYTHRO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE HYDROCHLORIDE; D-ERYTHRO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 6,8-DIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-, MONOHYDROCHLORIDE, (2S-TRANS)-; D-erythro-.alpha.-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1); D-erythro-|A-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1); D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride; D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, trans-alpha-; Methyl (2S-trans)-6,8-dideoxy-6-(((1-methyl-4-propylpyrrolidin-2-yl)carbonyl)amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside monohydrochloride; METHYL 6,8-DIDEOXY-6-(1-METHYL-TRANS-4-PROPYL-L-2-PYRROLIDINECARBOXAMIDO)-1-THIO-D-ERYTHRO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE MONOHYDROCHLORIDE; Methyl 6,8-dideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-D-erythro-alpha-D-galacto-octopyranoside--hydrogen chloride (1/1); N-[(1R,2R)-1-((4S,2R,3R,5R,6R)-3,4,5-trihydroxy-6-methylthio(2H-3,4,5,6-tetrah ydropyran-2-yl))-2-hydroxypropyl]((2S,4R)-1-methyl-4-propylpyrrolidin-2-yl)car boxamide, chlorideSynonyms